US Stock MarketDetailed Quotes

PRIM Primoris Services

Watchlist
  • 57.550
  • -3.460-5.67%
Close Mar 27 16:00 ET
  • 57.210
  • -0.340-0.59%
Pre 04:11 ET
3.10BMarket Cap17.39P/E (TTM)

Primoris Services Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Primoris Services Q4 2024 Earnings Date

Currency：USDFeb 24, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.59B
1.74B
+151.52M
Beat Est.
+4.90%
+14.90%
+9.53%
EPS
0.62
0.99
+0.37
Beat Est.
-9.81%
+43.48%
+59.09%
Analyst Rating
Strong Buy

Mar 26, 2025

Primoris Services Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.687B--
--2025/Q1-- / 1.482B--
Feb 24, 20252024/Q41.741B / 1.590B--
Nov 4, 20242024/Q31.649B / 1.594B--
Aug 5, 20242024/Q21.564B / 1.531B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.687B--
--2025/Q1-- / 1.482B--
Feb 24, 20252024/Q41.741B / 1.590B--
Nov 4, 20242024/Q31.649B / 1.594B--
Aug 5, 20242024/Q21.564B / 1.531B--

Unlock Free Earnings Estimates

Primoris Services Earnings Reports

  • Primoris Services | 10-K: FY2024 Annual Report

    Feb 25 13:02 ET

  • Primoris Services | 8-K: Primoris Services Corporation Reports Fourth Quarter and Full Year 2024 Results

    Feb 24 16:39 ET

  • Primoris Services | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 13:07 ET

  • Primoris Services | 8-K: Primoris Services Corporation Reports Third Quarter 2024 Results

    Nov 4, 2024 16:26 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +9.60%
    Hutchmed (China)
    HCM
    +7.31%
    eBay
    EBAY
    +1.88%
    Enerpac Tool
    EPAC
    +1.56%
    Halozyme Therapeutics
    HALO
    +1.03%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 26, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data